IP6 competitively inhibits AKT protein activity to block colon cancer proliferation [64] as well as to block the migratory ability and the expression of invasion-related markers of colorectal cancer cells in vitro [65]. The gene discussed is AKT1; the disease is malignant colon neoplasm.